Neo Comprehensive - Solid Tumor

Code
NTG-HCSX-02AX
Profile
Active-Compendium
81459x1. Add 88360x1 for PD-L1 IHC.
81479x1. If sample is insufficient to produce RNA fusion results but DNA SNV/indel and/or CNV results are reported, 81479x1 still applies. If only RNA fusion results are reported, use 81456x1 instead. Add 88360x1 for PD-L1 IHC.
Clinical
Oncology,Pathology
A block is preferred for testing: >20% tumor and >10 mm2 of tissue surface area for NGS (~500 tumor cells)(additional 100 neoplastic cells for PD-L1).
If submitting 5-micron unstained slides, the following number of slides are requested:
Samples with >25 mm2 of tissue: 10 unstained slides (2 sections per slide preferred)
Samples with 10-24 mm2 of tissue: 20 unstained slides (2 sections per slide preferred)
Please submit 1 additional unstained slide for H&E and 3 additional unstained slides if performing PD-L1 testing.
Flag Active
True
Orderable Test Description
<p>Neo Comprehensive - Solid Tumor is now <a href="https://www.neogenomics.com/providers/test/NTG-PTTT-03AX/neo-pantracer-tissue-formerly-neo-comprehensive-solid-tumor/" target="_blank" rel="noopener">NEO PanTracer Tissue</a></p>
Orderable Turn Around Time
8-10 Days
Meta Description
<p>Neo Comprehensive - Solid Tumor is now NEO PanTracer Tissue</p>
NY Approved
True
Keywords string
CGP, comprehensive genomic profile, microsatellite instability, MSI, tumor mutational burden, TMB, next generation sequencing, NGS, pan-solid tumor, PanTracer Tissue Neo Comprehensive - Solid Tumor
Title URL
neo-comprehensive-solid-tumor
TAT Details

NGS: 8-10 Days
IHC: 2 Days

Storage and transportation
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.